Celularity dismisses Deloitte as auditor, engages EisnerAmper; director Marc Mazur resigns

Celularity Inc

Deloitte & Touche dismissed as independent auditor effective Aug 2, 2024; prior reports contained going concern explanatory paragraph.
EisnerAmper LLP engaged as new auditor for FY 2024; will review interim Q1 and Q2 2024 financials.
Board member Marc Mazur resigned effective July 31, 2024; no disagreement with company.
No disagreements or reportable events occurred during Deloitte's engagement through dismissal.

item 4.01 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Marc Mazur

Director

CELU · Celularity Inc

Effective: 2024-07-31
Filed: August 5, 2024, 7:59 PM ET

On July 31, 2024, Marc Mazur, a Class III member of the Board of Directors of Celularity, notified the Board of Directors of his intention to resign as a member of the board and all committees thereof effective July 31, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Marc Mazur resigned as Director at Celularity Inc.

Action: resigned
Role: Director

Exact text from the filing

On July 31, 2024, Marc Mazur, a Class III member of the Board of Directors of Celularity, notified the Board of Directors of his intention to resign as a member of the board and all committees thereof effective July 31, 2024.

View on SEC.gov

Celularity Inc filing history →

Source: SEC EDGAR

accession 0001493152-24-030288

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.